Share this article on:

Neurology News: New Web Site for MS Therapies

doi: 10.1097/01.NNN.0000397241.94545.64
Departments: The Waiting Room

The The American Academy of Neurology (AAN) is working with a task force including the Multiple Sclerosis Coalition ( to make neurologists and the public aware of the benefits and risks of new medications for multiple sclerosis that have been approved by the U.S. Food and Drug Administration (FDA). This task force—called the Multiple Sclerosis Emerging Therapies Collaborative—has established a Web site at The site provides information for both neurologists and the public on new therapies as they emerge.

© 2011 American Academy of Neurology